143 related articles for article (PubMed ID: 25228833)
1. A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomerase.
Yu SJ; Won JK; Ryu HS; Choi WM; Cho H; Cho EJ; Lee JH; Kim YJ; Suh KS; Jang JJ; Kim CY; Lee HS; Yoon JH; Cho KH
Korean J Intern Med; 2014 Sep; 29(5):580-7. PubMed ID: 25228833
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
[TBL] [Abstract][Full Text] [Related]
5. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
7. Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
Won JK; Yu SJ; Hwang CY; Cho SH; Park SM; Kim K; Choi WM; Cho H; Cho EJ; Lee JH; Lee KB; Kim YJ; Suh KS; Jang JJ; Kim CY; Yoon JH; Cho KH
Hepatology; 2017 Sep; 66(3):855-868. PubMed ID: 28439950
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.
Yang X; Chen SL; Lin CS; Liu LL; Wang CH; Yun JP
Pathol Res Pract; 2020 Nov; 216(11):153153. PubMed ID: 32891822
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.
Yu SJ; Yoon JH; Yang JI; Cho EJ; Kwak MS; Jang ES; Lee JH; Kim YJ; Lee HS; Kim CY
J Bioenerg Biomembr; 2012 Feb; 44(1):101-15. PubMed ID: 22350012
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
11. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
[TBL] [Abstract][Full Text] [Related]
12. MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker.
Wang X; Wang Y; Zhang Q; Zhuang H; Chen B
Med Sci Monit; 2018 Mar; 24():1759-1767. PubMed ID: 29576605
[TBL] [Abstract][Full Text] [Related]
13. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
[TBL] [Abstract][Full Text] [Related]
14. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
Chen HL; OuYang HY; Le Y; Jiang P; Tang H; Yu ZS; He MK; Tang YQ; Shi M
Cancer Med; 2018 Nov; 7(11):5339-5350. PubMed ID: 30306706
[TBL] [Abstract][Full Text] [Related]
15. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
[TBL] [Abstract][Full Text] [Related]
18. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
19. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
20. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
Jin J; Zhu P; Liao Y; Li J; Liao W; He S
Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
